Skip to Main Content

Author Details

Gregory J Fermann
University of Cincinnati
1997
79
20
PMIDPaper TitleJournal TitlePublished Year
37794950Definition of factor Xa inhibitor-related, life-threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel.J Am Coll Emerg Physicians Open2023
37753225Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study.Res Pract Thromb Haemost2023
33118917Socio-demographic and trauma-related predictors of depression within eight weeks of motor vehicle collision in the AURORA study.Psychol Med2022
35434709Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department.J Am Coll Emerg Physicians Open2022
32989243Correction: The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure.Mol Psychiatry2021
33497508Sex-related differences in D-dimer levels for venous thromboembolism screening.Acad Emerg Med2021
33206126Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical Trial.JAMA Cardiol2021
32699994Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.Adv Ther2020
31745239The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure.Mol Psychiatry2020
32014375The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.Am J Emerg Med2020
33054507Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants.J Med Econ2020
29703562D-dimer levels in VTE patients with distal and proximal clots.Am J Emerg Med2019
32685588Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.J Health Econ Outcomes Res2019
32685582Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism.J Health Econ Outcomes Res2019
31288565TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial).Circ Heart Fail2019
31249975Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous Thromboembolism.TH Open2019
30729377The value of sPESI for risk stratification in patients with pulmonary embolism.J Thromb Thrombolysis2019
30312510Aortic Dissection Detection Risk Score: A Clinical Decision Rule That Needs Some Parenting.Acad Emerg Med2019
28843518Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis.Am J Emerg Med2018
29603819Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism.Acad Emerg Med2018
29656169International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.Thromb Res2018
28990334What's Next for Acute Heart Failure Research?Acad Emerg Med2018
27225840External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality.Clin Appl Thromb Hemost2017
28484958Markers of diuretic resistance in emergency department patients with acute heart failure.Int J Emerg Med2017
28193193Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.BMC Pulm Med2017
28132795Developing a standardized measurement of alcohol intoxication.Am J Emerg Med2017
28188268Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure).Circ Heart Fail2017
28185131External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.Intern Emerg Med2017
28097761Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.Int J Clin Pract2017
29016692Benefit of early discharge among patients with low-risk pulmonary embolism.PLoS One2017
28652016Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism.Clin Ther2017
28572743Design and rationale of the high-sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial.Pragmat Obs Res2017
28665208Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies.Curr Med Res Opin2017
28927177External validation of the multivariable 'In-hospital Mortality for PulmonAry embolism using Claims daTa' prediction rule in the Premier Hospital Database.Eur Heart J Qual Care Clin Outcomes2017
28891981Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure.J Clin Med2017
27757790Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin.Intern Emerg Med2017
27481875Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism?Clin Appl Thromb Hemost2017
26946105Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.Thromb Res2016
26575855External validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction rule.Int J Clin Pract2016
26577429Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.Am J Emerg Med2016
27770814External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications.BMC Health Serv Res2016
27262665Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group.J Card Fail2016
27168480In Reply.Acad Emerg Med2016
27324143Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.J Thromb Thrombolysis2016
27522388Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban.Int J Cardiol2016
27286136Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group.Acad Emerg Med2016
27548074Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.Pharmacotherapy2016
27181876Outcomes related to variation in hospital pulmonary embolus observation stay utilization.Hosp Pract (1995)2016
26910112Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis.Acad Emerg Med2016
26977136External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.Thromb J2016
  • 1 - 50 of 79

Recommended Authors

Phillip J Schulte
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 12
Rohan Khera
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Rashmee U Shah
University of Utah School of Medicine
Career Start Year 2009
Number of shared co-authors 2
Maame Yaa A B Yiadom
Stanford University
Career Start Year 2008
Number of shared co-authors 16
Aakriti Gupta
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Career Start Year 2008
Number of shared co-authors 0
Allan J Walkey
Boston University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Sean van Diepen
University of Alberta Hospital
Career Start Year 2004
Number of shared co-authors 8
Jeremiah S Hinson
Johns Hopkins School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Kevin F Kennedy
Saint Luke's Mid America Heart Institute
Career Start Year 2004
Number of shared co-authors 4
Andra L Blomkalns
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 12
Adrian F Hernandez
Duke University Medical Center
Career Start Year 2003
Number of shared co-authors 22
Steven M Bradley
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation
Career Start Year 2002
Number of shared co-authors 6
Daniel Mark Courtney
University of Texas Southwestern Medical Center
Career Start Year 2001
Number of shared co-authors 20
Benjamin C Sun
Leonard Davis Institute of Health Economics, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 14
Robert Birkhahn
NY Presbyterian Hospital
Career Start Year 1999
Number of shared co-authors 17
Kevin J Anstrom
University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 17
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Marie-Carmelle Elie
University of Florida Health Shands Hospital
Career Start Year 1997
Number of shared co-authors 1
John S Rumsfeld
Stanford University
Career Start Year 1997
Number of shared co-authors 12
Frederick A Masoudi
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 12
Andra L Blomkalns
Stanford University
Career Start Year 1994
Number of shared co-authors 28
Henry H Ting
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 10
Paul A Heidenreich
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 10
Harlan M Krumholz
Yale School of Medicine
Career Start Year 1988
Number of shared co-authors 16
James G Jollis
Duke Clinical Research Institute, Duke University School of Medicine
Career Start Year 1985
Number of shared co-authors 9
Donald Schreiber
Stanford University School of Medicine Palo Alto
Career Start Year 1983
Number of shared co-authors 17
Harry P Selker
Tufts Clinical and Translational Science Institute (CTSI), Tufts University
Career Start Year 1981
Number of shared co-authors 10
Robert J Zalenski
St. Joseph Mercy Oakland Hospital
Career Start Year 1981
Number of shared co-authors 16
Martha J Radford
New York University School of Medicine
Career Start Year 1979
Number of shared co-authors 6
Joseph Lee Garvey
Carolinas Medical Center
Career Start Year 1977
Number of shared co-authors 15

Collaborators

William F Peacock
Baylor College of Medicine
Co-authored papers 36
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 25
Alan B Storrow
Vanderbilt University Medical Center
Co-authored papers 19
Phillip D Levy
Wayne State University School of Medicine.
Co-authored papers 15
Douglas B Sawyer
Center for Molecular Medicine, Maine Medical Center Research Institute
Co-authored papers 12
Peter S Pang
Indiana University School of Medicine
Co-authored papers 12
Christopher J Lindsell
Duke University
Co-authored papers 12
Deborah B Diercks
UT Southwestern Medical Center
Co-authored papers 11
Karen F Miller
Vanderbilt University Medical Center
Co-authored papers 11
Judd E Hollander
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 8
Anna Marie Chang
Jefferson University Hospitals
Co-authored papers 8
Neal L Weintraub
Medical College of Georgia, Augusta University
Co-authored papers 7
JoAnn Lindenfeld
Vanderbilt University Medical Center
Co-authored papers 7
Cathy A Jenkins
Vanderbilt University Medical Center
Co-authored papers 7
Brian C Hiestand
Wake Forest School of Medicine
Co-authored papers 7
Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 6
Charles V Pollack
Thomas Jefferson University Hospital, Pennsylvania Sidney Kimmel Medical College
Co-authored papers 6
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 6
John A McPherson
Vanderbilt University Medical Center
Co-authored papers 5
Allen J Naftilan
Vanderbilt University Medical Center
Co-authored papers 5
W Brian Gibler
University of Cincinnati College of Medicine President
Co-authored papers 5
Gary Michael Felker
Duke University School of Medicine
Co-authored papers 5
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Co-authored papers 5
Matthew I Sperling
University of Cincinnati
Co-authored papers 5
David J Maron
Stanford University School of Medicine
Co-authored papers 5
James W Hoekstra
Wake Forest School of Medicine
Co-authored papers 5
William Frank Peacock
Baylor College of Medicine
Co-authored papers 4
Susan Roll
University of Cincinnati
Co-authored papers 4
Alexander T Limkakeng
Duke University
Co-authored papers 4
Stacey L House
Washington University School of Medicine
Co-authored papers 4
Release 1.2